720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Jean Mulcahy Levy, MD
- Hematology/Oncology - Pediatric
- Pediatrics
I strive to provide the best care for my patients. I believe in treating the patient and family as a whole.
Get to know Jean Mulcahy Levy, MD
- Craniopharyngioma
- Leukemia (Childhood)
- Pediatric Cancer
- English
My clinical interests focus on the care of children with tumors involving the brain and spinal cord, using a combination of therapies and coordinating services including surgery, radiation, and chemotherapy to improve outcomes for these patients.
Undergraduate 1998
University of Portland (OR)
Medical Education 2003
Oregon Health & Science University School of Medicine
Internship 2004
University of Arizona Program
Residency 2006
University of Arizona Program
Fellowship 2012
University of Colorado (Children's Hospital Colorado) Program
For Patients:
My research interests focus on autophagy, a multi-step process that cancer can use to survive. It is possible to block this survival mechanism and hopefully make cancer easier to kill with other treatments like radiation and chemotherapy. My research has three goals to improve survival of kids with brain tumors. First, find which step of the process should be blocked to kill the most tumor cells. Second, to find which brain tumors depend most on autophagy to survive. And finally, to determine if a specific genetic mutation found in some pediatric brain tumors can identify patients who will most benefit from autophagy directed treatments.
My research interests focus on autophagy, a multi-step process that cancer can use to survive. It is possible to block this survival mechanism and hopefully make cancer easier to kill with other treatments like radiation and chemotherapy. My research has three goals to improve survival of kids with brain tumors. First, find which step of the process should be blocked to kill the most tumor cells. Second, to find which brain tumors depend most on autophagy to survive. And finally, to determine if a specific genetic mutation found in some pediatric brain tumors can identify patients who will most benefit from autophagy directed treatments.
For Referring Providers:
My laboratory research focus is the study of autophagy, a multi-step cellular catabolic process that turns over long-lived proteins and organelles and contributes to cell and organism survival during nutrient deprivation and other stresses. Autophagy has been shown to be important in the development of cancer and is a promising target for manipulation to improve cancer treatment and survival. My goal is to determine how to utilize autophagy to improve therapy for patients with malignant central nervous system (CNS) tumors. I also have a translational research interest in using the power of laboratory findings to identify patients at higher risk of adverse neurocognitive outcomes due to the negative effects of radiation and chemotherapy.
My laboratory research focus is the study of autophagy, a multi-step cellular catabolic process that turns over long-lived proteins and organelles and contributes to cell and organism survival during nutrient deprivation and other stresses. Autophagy has been shown to be important in the development of cancer and is a promising target for manipulation to improve cancer treatment and survival. My goal is to determine how to utilize autophagy to improve therapy for patients with malignant central nervous system (CNS) tumors. I also have a translational research interest in using the power of laboratory findings to identify patients at higher risk of adverse neurocognitive outcomes due to the negative effects of radiation and chemotherapy.
Outstanding Abstract Award 2012
International Symposium on Pediatric Neuro-Oncology
